SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 61.50 |
| Enterprise Value ($M) | -35.71 |
| Book Value ($M) | 89.38 |
| Book Value / Share | 2.01 |
| Price / Book | 0.69 |
| NCAV ($M) | 75.18 |
| NCAV / Share | 1.69 |
| Price / NCAV | 0.82 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.49 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.56 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.10 |
| Current Ratio | 10.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 125.83 |
| Assets | 140.04 |
| Liabilities | 50.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | PFM Health Sciences, LP | |||
| 13G/A | Bank Of America Corp /de/ | 4.90 | 2.93 | |
| 13G/A | Rubric Capital Management LP | 3.05 | -31.08 | |
| 13G/A | Adage Capital Management, L.P. | 4.58 | ||
| 13D/A | Ra Capital Management, L.p. | 14.20 | 0.22 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 38,680 | 225,486 | 17.15 | |
| 84,666 | 205,802 | 41.14 | |
| 45,474 | 112,201 | 40.53 | |
| 26,201 | 108,245 | 24.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GOSS – Gossamer Bio, Inc. | HALO – Halozyme Therapeutics, Inc. |
| HLVX – HilleVax, Inc. | HUMA – Humacyte, Inc. |
| IBRX – ImmunityBio, Inc. |
Financial data and stock pages provided by
Fintel.io